Creating New Value for Biopharma

| October 23, 2017

article image
In this paper we envisage future opportunities for value creation by the global biopharma industry. We set these opportunities in the context of an evolving healthcare ecosystem which continually creates new business opportunities and challenges for the industry. We illustrate our ideas with some examples and reflect on the actions which the industry needs to consider.

Spotlight

Pharma Partners

Autorizzata da AIFA al confezionamento secondario di farmaci, l'Azienda è anche certificata ISO 13485 per il confezionamento secondario di medical devices e prodotti diagnostici. L'Azienda offre ai propri clienti un servizio con standard elevati di qualità, nel rispetto dei tempi di consegna ed a prezzi competitivi. La definizione delle Responsabilità avviene tramite la stipula di Quality Agreements con i clienti prima dell'inizio di una nuova lavorazione. L'Azienda esegue confezionamenti secondari, riconfezionamenti, sostituzione di componenti, etichettatura, allestimento espositori, allestimento kit diagnostici multicomponente. L'Azienda, pur di recente fondazione, è riuscita a consolidare rapporti stabili con clienti farmaceutici e diagnostici di rilevanza nazionale ed internazionale.

OTHER ARTICLES

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Spotlight

Pharma Partners

Autorizzata da AIFA al confezionamento secondario di farmaci, l'Azienda è anche certificata ISO 13485 per il confezionamento secondario di medical devices e prodotti diagnostici. L'Azienda offre ai propri clienti un servizio con standard elevati di qualità, nel rispetto dei tempi di consegna ed a prezzi competitivi. La definizione delle Responsabilità avviene tramite la stipula di Quality Agreements con i clienti prima dell'inizio di una nuova lavorazione. L'Azienda esegue confezionamenti secondari, riconfezionamenti, sostituzione di componenti, etichettatura, allestimento espositori, allestimento kit diagnostici multicomponente. L'Azienda, pur di recente fondazione, è riuscita a consolidare rapporti stabili con clienti farmaceutici e diagnostici di rilevanza nazionale ed internazionale.

Events